Matinas BioPharma Holdings, Inc. (MTNB)

MTNB Revenue

Matinas BioPharma Holdings had revenue of $4.28M in the twelve months ending September 30, 2023, with 98.43% growth year-over-year. In the year 2022, Matinas BioPharma Holdings had annual revenue of $3.19M with 9,560.61% growth.

• Revenue (ttm): $4.28M
• Revenue Growth: +98.43%
• P/S Ratio: 12.66
• Revenue / Employee: $126,000
• Employees: 34
• Market Cap: 54.23M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2022	3.19M	3.16M	9,560.61%
Dec 31, 2021	33.00K	-	-
Dec 31, 2020	0	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	0	-	-
Dec 31, 2017	0	-	-
Dec 31, 2016	0	-	-
Dec 31, 2015	0	-	-
Dec 31, 2014	0	-	-
Dec 31, 2013	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.